NCT07661290 Effect of High-Power Laser Therapy on Disc Morphology and Functional Outcome in Patients With Cervical Radiculopathy
| NCT ID | NCT07661290 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cairo University |
| Condition | Radiculopathy |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2026-07-10 |
| Primary Completion | 2026-11-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2026-07-10 with a primary completion date of 2026-11-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study aims to evaluate the effectiveness of high-power laser therapy (HPLT) in patients with cervical radiculopathy, focusing on its impact on disc morphology, and overall functional activity
Eligibility Criteria
Inclusion Criteria: \- Adults aged between 40 to 60 years. • A Body Mass Index (BMI) range of 18.5-35 (normal to overweight) will be required. • Diagnosed with cervical radiculopathy, confirmed by clinical examination and diagnostic imaging (e.g., MRI). • Pain intensity level of at least 4 on the Visual Analog Scale (VAS). • No previous history of surgery on the cervical spine. • Able to provide informed consent and participate in the study protocol. Exclusion Criteria: * Pregnant women or those planning to become pregnant. • Individuals with severe comorbidities that could interfere with the study, such as uncontrolled diabetes, cancer, or systemic inflammatory diseases. Individuals with severe cervical stenosis or spinal cord compression. • Individuals any form of malignancy, active infection, or dermatological issues on the neck. • Patients using opioid analgesics or other strong pain medications that could alter the results. • Previous treatment with high-power laser therapy within the last six months.
Contact & Investigator
Hussein Ahmed Shaker
STUDY CHAIR
Professor, Cairo university
Frequently Asked Questions
Who can join the NCT07661290 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 60 Years, studying Radiculopathy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07661290 currently recruiting?
Yes, NCT07661290 is actively recruiting participants. Contact the research team at daiana.mushtaha@gmail.com for enrollment information.
Where is the NCT07661290 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT07661290 clinical trial?
NCT07661290 is sponsored by Cairo University. The principal investigator is Hussein Ahmed Shaker at Professor, Cairo university. The trial plans to enroll 60 participants.